Home > Browse Research > Life Sciences > Diagnostics > In Vitro Diagnostics > Companion Diagnostics

Companion Diagnostics: market research reports

Companion Diagnostics are assays intended to assist physicians in making treatment decisions. These may include tests that are being developed in conjunction, or as a companion to the drug.
They may also be tests that have been developed after a drug has come to market. The use of a diagnostic test to determine the viability of using a particular pharmaceutical product to treat a patient can be called companion diagnostics or pharmacodiagnostics.

Companion Diagnostics market research reports and industry analysis

The Complete Guide to Companion Diagnostics: Market Environment Products and Companies 11/21/2012 \| published by: Espicom Healthcare Intelligence ... patients who will benefit most from, or suffer fewer side effects from targeted therapies, and thereby present a more compelling approval and prescribing case to regulators and clinicians. It could prove to be a lifesaver ... \| more... Search inside this report	$1,740.00
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes 11/9/2012 \| published by: GBI Research ... Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and analysis on the major trends and issues affecting biomarkers in the drug discovery process. The report describes the history of biomarkers and their role in fulfilling ... \| more... Search inside this report	$3,500.00
Companion Diagnostics and Personalized Medicine Market Report 2012 8/1/2012 \| published by: Select Biosciences Limited ... aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine. Companion Diagnostics has been rapidly expanding over the past 3 years and in this ... \| more...	$1,970.00
Key Findings: In Vitro Diagnostics M&A and Deal Trends 7/17/2012 \| published by: Business Insights ... treatments in the emerging companion diagnostic market. Features and benefits An overview of IVD industry trends by geography, technology type, and leading players. Analysis of partnership deal and M&A activity in the IVD market, including ... \| more... Search inside this report	$1,910.00
Molecular Diagnostics: Companion Diagnostics and Personalized Medicine 5/31/2012 \| published by: Datamonitor ... so-called companion diagnostic, which typifies this movement. Features and benefits Full assessment of the market drivers and resistors for the personalized medicine movement. Detailed overview of the key pharmaceutical-diagnostic collaborative deals signed over the past ... \| more... Search inside this report	$1,900.00
Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth 3/27/2012 \| published by: GlobalData ... provides information and analysis on the global companion diagnostics market. The report provides information such as current trends and developments in the global companion diagnostics market (including recent deals and industry trends). The report also ... \| more... Search inside this report	$500.00
Companion Diagnostics Partnering Terms and Agreements 2/1/2012 \| published by: Current Partnering ... and analysis of how and why companies enter companion diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ... \| more... Search inside this report	$2,695.00
Companion Diagnostics and Biomarker Development: Partnership Strategies and Benchmarks 2/1/2012 \| published by: Cutting Edge Information ... the ability to target specific patient populations — unleashing the potential for greater efficacy, accelerated regulatory approval and better reimbursement. Clarify your decision making with this report’s in-depth data benchmarks and best practices from leading ... \| more...	$7,695.00
Companion Diagnostics in Personalized Medicine and Cancer Therapy 2/1/2012 \| published by: TriMark Publications ... of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded over the past twenty years, expanding by more than ... \| more...	$3,400.00
Pharmacogenomics Partnering Terms and Agreements 2/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. ... \| more... Search inside this report	$2,695.00
Companion Diagnostics 9/1/2011 \| published by: Global Industry Analysts ... period 2008 through 2017. The report profiles 101 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, bioMérieux, Clarient Inc., LabCorp, Merck & Co. Inc., Myriad Genetics, Inc., Power3 Medical Products, ... \| more...	$4,200.00
Companion Diagnostics: World Market Outlook 2011-2021 8/22/2011 \| published by: Visiongain ... the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict ... \| more...	$2,416.00
Companion Diagnostics Partnering Terms and Agreements 4/1/2011 \| published by: Current Partnering ... understanding and analysis of how and why companies enter companion diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ... \| more... Search inside this report	$2,695.00
Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development 3/4/2011 \| published by: Datamonitor ... disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy. Scope of this research In-depth analysis of companion diagnostic development - ... \| more... Search inside this report	$1,900.00
In-vitro and Companion Diagnostics Industry - 2010 Yearbook 1/21/2011 \| published by: GBI Research ... report provides a market landscape, competitive landscape and market trends information on the following market categories: - clinical chemistry, immunochemistry, hematology, histology and cytology, microbiology, infectious immunology, genetic testing and companion diagnostics. The report provides ... \| more... Search inside this report	$3,500.00
Companion Diagnostics: Technologies and Global Markets 11/1/2010 \| published by: BCC Research ... Valued at $170 million in 2010, analysts believe that by 2015, Oncotype Dx for breast cancer risk recurrence and drug regimen may reach $300 million, a compound annual growth rate (CAGR) of 12%. The approval ... \| more...	$4,850.00
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies 5/1/2010 \| published by: Arrowhead Publishers ... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ... \| more... Search inside this report	$2,495.00
U.S. Companion Diagnostics Markets 12/29/2009 \| published by: Frost & Sullivan ... key analysis and findings pertaining to the market. In addition, industry challenges and strategies for growth are in depth for the U.S. companion diagnostics market. Key developing business models in the market are also discussed. \| more...	$6,000.00
Disruption or Advantage? Update on Companion Diagnostics 9/15/2009 \| published by: Decision Resources ... diagnostics can be used to predict drug response and treatment effi cacy- therefore, companion diagnostics are also the perfect means to fulfi llment of the promise of personalized medicine. But the advantages of companion diagnostics ... \| more...	$4,600.00
Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics 8/1/2008 \| published by: Kalorama Information ... the important areas that will have a transforming impact on the diagnostic industry: Companies are now performing diagnostic tests as a service rather than simply selling kit to laboratories. Are companies seeking profit, or a ... \| more... Search inside this report	$2,995.00
The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends 6/5/2008 \| published by: Decision Resources ... drug because of their particular metabolic activity. The concept of companion diagnostics as an integral component of personalized medicine-RxDx-is an emerging and critical paradigm for drug development and use. What is driving that paradigm? Get ... \| more...	$1,125.00
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine) 6/1/2008 \| published by: Kalorama Information ... the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as ... \| more... Search inside this report	$2,995.00
Monoclonal Therapeutics and Companion Diagnostic Products 1/1/2008 \| published by: BCC Research ... We were particularly interested in the position of the antibody market in the immediate future compared to how it has performed in the recent past as well as how the market compares to that of ... \| more...	$4,850.00
Companion Diagnostics: Enabling Personalized Medicines in Cancer 10/26/2006 \| published by: Decision Resources ... critical biomarkers, however, they also need to consider technology options, potential diagnostics partners, and regulatory hurdles. Get the Answers You Need to Shape Your Strategy Companion diagnostics are becoming an integral part of the design ... \| more...	$4,600.00
Guide to Business and Regulatory Strategies: Companion Diagnostic Products and Individual Therapies 6/1/2006 \| published by: Drug and Market Development Publishing ... information for those interested in developing companion diagnostics, as well as stand-alone diagnostics. Introduction Five years after the historic completion of the Human Genome Sequencing Project, personalized nutrition and medicine are fields evolving with an ... \| more... Search inside this report	$795.00

Research assistance

Matching geography

Start new browse

Join Alert Me now!

Companion Diagnostics: market research reports

Companion Diagnostics market research reports and industry analysis